Novavax (NVAX) stock jumps as the company beats with its Q4 2025 revenue and records full-year profitability. Read more here.
Market sentiment among individual investors grew more cautious in late February, according to the latest survey from the American Association of Individual Investors. Bullish sentiment declined to ...
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results